Biosensors for detection of SARS-CoV-2 are less sensitive than the routinely used rapid antigen tests.

Paxlovid is:

Polymer-based nanoformulations may be manufactured from:

Vaccines against SARS-CoV-2 were developed too fast, therefore, their methodology is potentially unsafe.

Since SARS-CoV-2 is very new, repurposed drugs cannot be used for treatment of the associated infection.

Leave a Reply